Seda Baykal-Köse

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 11, 2024
Phenotypically plastic drug-resistant chronic myeloid leukaemia cell line displays enhanced cellular dynamics in a zebrafish xenograft model.

Seda Baykal, Zeynep Yuce, Gunes Ozhan

|Apr 07, 2023
ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia

Seda Baykal-Köse, Maud Voldoire, Christophe Desterke

|Feb 28, 2020
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells.

Seda Baykal-Köse, Eda Acikgoz, Ahmet Sinan Yavuz

|Aug 10, 2018
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).

Melanie Gentil, Patricia Hugues, Christophe Desterke

Pageof 1

Frequent Collaborators

2 joint publications

Ali G Turhan

2 joint publications

Zeynep Yuce

1 joint publications

Lucas E B Souza

1 joint publications

Gunes Ozhan